COVID-19 Research Specific Information
- Reporting Health and Safety Protocol Violations: If a student or faculty or staff member observes an individual or group whom they suspect is not acting in accordance with established health and safety protocols, they can report these incidents through the COVID-19 Incident Report Form. Reports will be referred to the relevant campus official for follow up.
- Georgetown University Plan to Restart On-Campus Research (added 9/24/2020)
- Restarting Research FAQ (added 7/6/2020)
- Click here for the research access request form
- Restarting Research Update: This link (new window) takes you to a Box folder with the floor plans for GUMC work spaces. When submitting your research plan in GMS, each investigator must clearly show on the floor plan where and how you are going to space out personnel in accordance with the guidelines outlined in “Restarting Research Activities at Georgetown: a phased approach. (new window)” Restarting research plans will not be approved without the appropriate floor plans.
- New OMB Information: On Thursday, June 18, 2020, the Office of Management and Budget (OMB) posted a memo: Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operation (new window). The memo extends the allowability of salary on federal grants to Sept 30, 2020.
- For Research Continuity Guidance and COVID-19 and Human Subjects Research Guidance and FAQs, see the main GUMC COVID-19 page.
GUMC COVID-19 Call for Research Proposals: We would like to determine who on our campus has a great idea to carry out COVID-19 relevant research but cannot do so because of current research continuity policies. This would include dry lab, wet lab and clinical trial research. Many of our peer institutions have doubled down on such research, even as they take appropriate social distancing precautions that limit other forms of research activity. As a research university, we have an obligation to be part of the solution if we have the capacity to contribute.
We will be offering a group brainstorming session, via Zoom, on Monday, March 30th at 1PM for those who are interested.
If you have a high-priority COVID-19 focused project in mind, please submit a one-two page proposal by Wednesday, April 1st. We will select the most promising proposals, and will work with successful applicants to determine how to best execute the project in their laboratories while adhering to appropriate social distancing requirements. Exemptions to current research continuity guidelines will be granted ONLY to successful applicants.
Do not submit budgets with these submissions. Small amounts of funding (personnel costs are not permitted) may be available for well justified critical supplies or reagents for proposals that are selected for further consideration. We anticipate supporting no more than five meritorious proposals using this mechanism.
Criteria for successful applications will be:
Relevance to COVID-19 pandemic
Potential impact of the work
Feasibility, including potential for rapid clinical translation
Quality of the science
- From the COVID-19 HPC Consortium: help combat the COVID-19 pandemic by making sure our researchers are aware of available research computing resources: Info about the HPC Consortium (https://covid19-hpc.mybluemix.net/) | XSEDE portal for HPC Consortium (https://www.xsede.org/covid19-hpc-consortium)
- Through the COVID-19 and Its Cardiovascular Impact Rapid Response Grant initiative, the American Heart Association will fund one national coordinating center along with at least 10 project grants of $100,000 each. The application will consist of a two- to three-page proposal, accompanied by the applicant’s NIH biosketch. Applicants interested in heading the coordinating center will attach an additional 300-word qualifications statement. Applications due by April 6. Learn more (https://professional.heart.org/professional/ResearchPrograms/UCM_505867_AHA-Rapid-Response-Grant-COVID-19-and-its-Cardiovascular-Impact.jsp?utm_source=owned&utm_medium=email&utm_campaign=aha+rapid+response+grant+covid19+email+03252020)
- Department of the Army: RFP –Prototype Development to Combat Novel Coronavirus Disease COVID-19 https://beta.sam.gov/opp/53badf9fb02349e78839a541495efc6a/view
- CDC – CDC-RFA-OT18-18020202SUPP20 Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health
- NSF – NSF 20-065 Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 (nsf20065) | NSF
- NSF – NSF 20-052 Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (nsf20052) | NSF
- NHLBI – NOT-HL-20-757: Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
- NIAID/NIGMS – NOT-AI-20-030: Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)
- NIAID – NOT-AI-20-031: Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
- NIAID – NOT-AI-20-034: Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
- NIDA – NOT-DA-20-047: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
- NIGMS – NOT-GM-20-025: Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
- NCATS – NOT-TR-20-011: Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
- NCATS – NOT-TR-20-012: Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
- Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) (article posted May 18, 2020)
- Update on COVID-19 Flexibilities for the Research Community (video posted March 26, 2020)
- A supplement to keep scientists on track at critical life junctions (article posted March 18, 2020)
- Interview With Francis Collins of NIH (article posted March 17, 2020)
Other Organizations’ COVID-19 pages, resources, and announcements
- Council On Government Relations – Institutional and Agency Responses to COVID-19 and Additional Resources
- NIH – Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
- NIH Updates:
- NOT-OD-20-091– UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
- NOT-OD-20-083 – General Frequently Asked Questions (FAQs) – Proposal Submission and Award Management Related to COVID-19
- NOT-OD-20-086 – Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
- NOT-OD-20-087 – Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
- NSF – Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees (nsf20053) | NSF
- DOD – Frequently Asked Questions for DOD Research Proposers and Awardees Impacted by the Novel Coronavirus (COVID-19)
- JDRF Coronavirus Page: https://www.jdrf.org/coronavirus/
- AHA – COVID-19 Professional Resources